Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for NVAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -1.727M
March 31, 2026 8.158M
December 31, 2025 0.33M
September 30, 2025 -0.82M
June 30, 2025 0.428M
March 31, 2025 4.86M
December 31, 2024 0.666M
September 30, 2024 -0.415M
June 30, 2024 -258.58M
March 31, 2024 -6.246M
December 31, 2023 -102.71M
September 30, 2023 -195.36M
June 30, 2023 -61.79M
March 31, 2023 -0.543M
December 31, 2022 -69.14M
September 30, 2022 0.983M
June 30, 2022 0.268M
March 31, 2022 -180.70M
December 31, 2021 -3.32M
September 30, 2021 5.462M
June 30, 2021 -2.804M
March 31, 2021 -588.96M
December 31, 2020 -435.25M
September 30, 2020 -43.04M
June 30, 2020 -416.62M
Date Value
March 31, 2020 -185.92M
December 31, 2019 -30.17M
September 30, 2019 -12.03M
June 30, 2019 -0.003M
March 31, 2019 -56.18M
December 31, 2018 -3.857M
September 30, 2018 -1.02M
June 30, 2018 -54.00M
March 31, 2018 -43.92M
December 31, 2017 -17.42M
September 30, 2017 -23.63M
June 30, 2017 -8.15M
March 31, 2017 -15.38M
December 31, 2016 -0.009M
September 30, 2016 -1.419M
June 30, 2016 -0.374M
March 31, 2016 -2.00M
December 31, 2015 -0.361M
September 30, 2015 -8.807M
June 30, 2015 -4.232M
March 31, 2015 -195.68M
December 31, 2014 -0.501M
September 30, 2014 -0.774M
June 30, 2014 -108.06M
March 31, 2014 -1.345M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Moderna, Inc. -23.00M
Merck & Co., Inc. 714.00M
Pfizer Inc. 0.00
Recursion Pharmaceuticals, Inc. 0.00
Agenus, Inc. -14.71M